| # | Drug | Count |
|---|---|---|
| 0 | DOXAZOSIN | 7 |
| 1 | DOXAZOSIN MESYLATE | 7 |
| 2 | ROSUVASTATIN | 7 |
| 3 | EMPAGLIFLOZIN | 6 |
| 4 | NEBIVOLOL | 6 |
| 5 | NEBIVOLOL HYDROCHLORIDE | 6 |
| 6 | CANDESARTAN | 4 |
| 7 | FUROSEMIDE | 4 |
| 8 | ADRENALINUM | 3 |
| 9 | AMLODIPINE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DINOPROSTONE | 3 | 0.0037 |
| 1 | METHYLDOPA | 3 | 0.0006 |
| 2 | DESFLURANE | 1 | 0.0006 |
| 3 | CLOFARABINE | 1 | 0.0004 |
| 4 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 3 | 0.0004 |
| 5 | BUPIVACAINE | 3 | 0.0003 |
| 6 | CEFAZOLIN SODIUM | 3 | 0.0002 |
| 7 | LABETALOL | 3 | 0.0002 |
| 8 | NITRIC OXIDE | 1 | 0.0002 |
| 9 | NOREPINEPHRINE BITARTRATE | 3 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 6 | 0.0001 |
| 4 | Catecholamine [EPC] | 3 | 0.0000 |
| 5 | Amide Local Anesthetic [EPC] | 3 | 0.0000 |
| 6 | beta-Adrenergic Blocker [EPC] | 10 | 0.0000 |
| 7 | Prostaglandin Analog [EPC] | 3 | 0.0000 |
| 8 | General Anesthetic [EPC] | 1 | 0.0000 |
| 9 | Aldosterone Antagonist [EPC] | 3 | 0.0000 |